BioStem Technologies, Inc.
BSEM · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $301,827 | $16,685 | $6,875 | $4,341 |
| % Growth | 1,708.9% | 142.7% | 58.4% | – |
| Cost of Goods Sold | $13,746 | $1,262 | $882 | $1,475 |
| Gross Profit | $287,860 | $15,424 | $5,993 | $2,866 |
| % Margin | 95.4% | 92.4% | 87.2% | 66% |
| R&D Expenses | $1,911 | $342 | $123 | $120 |
| G&A Expenses | $18,690 | $10,646 | $10,432 | $4,188 |
| SG&A Expenses | $254,749 | $22,633 | $10,207 | $4,188 |
| Sales & Mktg Exp. | $236,058 | $11,986 | $0 | $0 |
| Other Operating Expenses | $0 | $229 | $345 | $164 |
| Operating Expenses | $256,660 | $23,204 | $10,675 | $4,472 |
| Operating Income | $31,201 | -$7,779 | -$4,682 | -$1,606 |
| % Margin | 10.3% | -46.6% | -68.1% | -37% |
| Other Income/Exp. Net | -$587 | -$704 | -$2,550 | $194 |
| Pre-Tax Income | $30,613 | -$8,483 | -$7,114 | -$1,412 |
| Tax Expense | -$1,271 | $0 | $0 | $0 |
| Net Income | $31,884 | -$8,483 | -$7,075 | -$1,445 |
| % Margin | 10.6% | -50.8% | -102.9% | -33.3% |
| EPS | 1.95 | -0.62 | -0.62 | -0.12 |
| % Growth | 414.5% | 0% | -416.7% | – |
| EPS Diluted | 1.47 | -0.62 | -0.62 | -0.12 |
| Weighted Avg Shares Out | 16,368 | 13,707 | 11,405 | 11,685 |
| Weighted Avg Shares Out Dil | 21,698 | 13,707 | 11,405 | 11,685 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $587 | $700 | $468 | $526 |
| Depreciation & Amortization | $293 | $229 | $243 | $284 |
| EBITDA | $31,494 | -$7,554 | -$6,520 | -$602 |
| % Margin | 10.4% | -45.3% | -94.8% | -13.9% |